These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21876312)

  • 1. Effect of adding levamisole on seroconversion response to hepatitis B virus vaccination in hemodialysis patients: a single-center experience.
    Sanadgol H; Khoshnoodi M; Mashhadi MA; Forghani MS
    Iran J Kidney Dis; 2011 Sep; 5(5):338-41. PubMed ID: 21876312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
    Sali S; Alavian SM; Hajarizadeh B
    Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
    Alavian SM; Tabatabaei SV
    Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
    Kayataş M
    Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
    Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
    Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of levamisole supplementation on tetanus vaccination response rates in haemodialysis patients: a randomized double-blind placebo-controlled trial.
    Fallahzadeh MK; Sajjadi S; Singh N; Khajeh M; Sagheb MM
    Nephrology (Carlton); 2014 Jan; 19(1):27-31. PubMed ID: 24341659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of response to anti-HBV infection in patients on maintenance hemodialysis infected with hepatitis C virus (HCV)].
    Muszytowski M; Manitius J; Ruszkiewicz-Fołda M
    Przegl Lek; 1996; 53(5):417-9. PubMed ID: 8754404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Seroconversion and immune response after anti-HBV vaccination in patients on chronic hemodialysis: comparison of two vaccines].
    Polito P; Di Lullo L; Iannacci GR; Cecilia A; Galderisi C; Gorini A
    G Ital Nefrol; 2011; 28(5):525-30. PubMed ID: 22028266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders.
    Lin C; Zhu J; Zheng Y; Chen Y; Wu Z; Chong Y; Gao Z
    J Infect; 2010 Apr; 60(4):264-70. PubMed ID: 20138189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AM3 (Inmunoferón) as an adjuvant to hepatitis B vaccination in hemodialysis patients.
    Pérez-García R; Pérez-García A; Verbeelen D; Bernstein ED; Villarrubia VG; Alvarez-Mon M
    Kidney Int; 2002 May; 61(5):1845-52. PubMed ID: 11967036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
    de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroconversion rates of two different doses of hepatitis B vaccine in Turkish haemodialysis patients.
    Oguz Y; Doganci L; Vural A
    Cent Eur J Public Health; 2001 Feb; 9(1):44-5. PubMed ID: 11243591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.
    Liu YL; Kao MT; Huang CC
    Vaccine; 2005 Jun; 23(30):3957-60. PubMed ID: 15917117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
    Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
    Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.